Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
Public ClinicalTrials.gov record NCT00909545. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Phase II Double-Blind, Placebo-Controlled, Tolerability and Dosage Finding Study of Isradipine CR as a Disease Modifying Agent in Patients With Early Parkinson Disease
Study identification
- NCT ID
- NCT00909545
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Northwestern University
- Other
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Interventions
- Isradipine CR 10mg Drug
- Isradipine CR 20mg Drug
- Isradipine CR 5mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2009
- Primary completion
- Nov 30, 2011
- Completion
- Jan 31, 2012
- Last update posted
- Apr 16, 2013
2009 – 2012
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Parkinson Institute | Sunnyvale | California | 94805 | — |
| Institute for Neurodegenerative Disorders | New Haven | Connecticut | 06510 | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | — |
| University of Miami | Miami | Florida | 33136 | — |
| University of South Flordia | Tampa | Florida | 33606 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30329 | — |
| Pacific Health Institute | Honolulu | Hawaii | 96817 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Boston University | Boston | Massachusetts | 02118 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Park Nicolet Clinic | Golden Valley | Minnesota | 55427 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| University of Rochester | Rochester | New York | 14618 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| University of Tennessee | Memphis | Tennessee | 38104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00909545, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2013 · Synced Apr 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00909545 live on ClinicalTrials.gov.